Release Date: 29/09/20 15:32 Summary: Notice of Extraordinary General Meeting Price Sensitive: No Download Document 1.27MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%